Adult Attention Deficit Hyperactivity Disorder (ADHD) Study With Amphetamine Sulfate

PHASE3CompletedINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

September 18, 2018

Primary Completion Date

April 12, 2019

Study Completion Date

April 12, 2019

Conditions
Attention Deficit Hyperactivity Disorder
Interventions
DRUG

Amphetamine Sulfate

active experimental AR19

DRUG

Placebo

Matching placebo

Trial Locations (31)

10549

118: Bioscience Research, LLC, Mount Kisco

29464

126: Coastal Carolina Research, Mt. Pleasant

30060

104: Northwest Behavioral Research Center, Marietta

32607

129: Sarkis Clinical Trials, Gainesville

32751

120: Meridien Research, Maitland

32763

130: Medical Research Group of Central Florida, Orange City

32803

123: APG Research, LLC, Orlando

32806

115: Clinical Neuroscience Solutions (CNS), Inc., Orlando

33805

105: Meridien Research, Lakeland

33912

103: Gulfcoast Clinical Research Center, Fort Myers

34201

108: Meridien Research, Bradenton

38119

102: Clinical Neuroscience Solutions (CNS), Inc., Memphis

132: Research Strategies of Memphis, Memphis

44718

119: Neurobehavioral Clinical Research, Inc., Canton

48307

134: Rochester Center for Behavioral Medicine, Rochester Hills

48314

128: Clinical Neurophysiology Services, Sterling

60048

113: Capstone Clinical Research, Libertyville

75231

110: FutureSearch Trials of Dallas, Dallas

77005

117: Houston Clinical Trials, LLC, Houston

78759

125: Biobehavioral Research of Austin, Austin

84405

109: Ericksen Research and Development, Clinton

86342

131: Advanced Clinical Research, Inc., Meridian

89128

107: Center for Psychiatry and Behavioral Medicine, Las Vegas

91316

114: Pharmacology Research Institute, Encino

92660

124: Pharmacology Research Institute, Newport Beach

92845

133: Collaborative Neuroscience Network, Garden Grove

97210

106: Summit Research Network, Portland

06416

121: CT Clinical Research Associates, Cromwell

08009

116: Alliance - Hassman Research Institute, Berlin

08002

127: Center for Emotional Fitness, Cherry Hill

08540

101: Princeton Medical Institute, Princeton

Sponsors
All Listed Sponsors
lead

Arbor Pharmaceuticals, Inc.

INDUSTRY

NCT03659929 - Adult Attention Deficit Hyperactivity Disorder (ADHD) Study With Amphetamine Sulfate | Biotech Hunter | Biotech Hunter